Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean D Sullivan

Showing results (191-200 of 325) with videos related to

Pageof 33
Sort By:
Journal of Oncology Practice|May 7, 2015
Projected Clinical, Resource Use, and Fiscal Impacts of Implementing Low-Dose Computed Tomography Lung Cancer Screening in MedicareJoshua A Roth, Sean D Sullivan, Bernardo H L Goulart, et al.
The American Journal of Managed Care|April 14, 2006
Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic testsScott D Ramsey, David L Veenstra, Louis P Garrison, et al.
JCO Precision Oncology|January 23, 2023
Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World DataCarsten Bokemeyer, Noman Paracha, Ulrik Lassen, et al.
Academic Pathology|November 23, 2020
Application of Health Technology Assessment (HTA) to Evaluate New Laboratory Tests in a Health System: A Case Study of Bladder Cancer TestingErik J Landaas, Ashley M Eckel, Jonathan L Wright, et al.
The American Journal of Managed Care|July 11, 2007
Quality of clinical and economic evidence in dossier formulary submissionsFernando Colmenero, Sean D Sullivan, Jennifer A Palmer, et al.
Clinical Therapeutics|March 26, 2013
Estimating the cost-effectiveness of onabotulinumtoxinA for neurogenic detrusor overactivity in the United StatesJosh J Carlson, Ryan N Hansen, Roger R Dmochowski, et al.
Journal of Neurotrauma|March 23, 2012
Utilization and costs of health care after geriatric traumatic brain injuryHilaire J Thompson, Sharada Weir, Frederick P Rivara, et al.
Annals of Surgery|October 7, 2011
The use, safety and cost of bariatric surgery before and after Medicare's national coverage decisionDavid R Flum, Steve Kwon, Kara MacLeod, et al.
Journal of Hospital Medicine|March 27, 2015
A multifaceted hospitalist quality improvement intervention: Decreased frequency of common labsAdam H Corson, Vincent S Fan, Travis White, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 6, 2022
Comparison of Alternative Methods to Assess the Cost-Effectiveness of Tumor-Agnostic Therapies: A Triangulation Approach Using Larotrectinib as a Case StudyAndrew Briggs, Beth Wehler, Jennifer G Gaultney, et al.
Pageof 33

Showing results (191-200 of 325) with videos related to

Sort By:
Pageof 33
Journal of Oncology Practice|May 7, 2015
Projected Clinical, Resource Use, and Fiscal Impacts of Implementing Low-Dose Computed Tomography Lung Cancer Screening in MedicareJoshua A Roth, Sean D Sullivan, Bernardo H L Goulart, et al.
The American Journal of Managed Care|April 14, 2006
Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic testsScott D Ramsey, David L Veenstra, Louis P Garrison, et al.
JCO Precision Oncology|January 23, 2023
Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World DataCarsten Bokemeyer, Noman Paracha, Ulrik Lassen, et al.
Academic Pathology|November 23, 2020
Application of Health Technology Assessment (HTA) to Evaluate New Laboratory Tests in a Health System: A Case Study of Bladder Cancer TestingErik J Landaas, Ashley M Eckel, Jonathan L Wright, et al.
The American Journal of Managed Care|July 11, 2007
Quality of clinical and economic evidence in dossier formulary submissionsFernando Colmenero, Sean D Sullivan, Jennifer A Palmer, et al.
Clinical Therapeutics|March 26, 2013
Estimating the cost-effectiveness of onabotulinumtoxinA for neurogenic detrusor overactivity in the United StatesJosh J Carlson, Ryan N Hansen, Roger R Dmochowski, et al.
Journal of Neurotrauma|March 23, 2012
Utilization and costs of health care after geriatric traumatic brain injuryHilaire J Thompson, Sharada Weir, Frederick P Rivara, et al.
Annals of Surgery|October 7, 2011
The use, safety and cost of bariatric surgery before and after Medicare's national coverage decisionDavid R Flum, Steve Kwon, Kara MacLeod, et al.
Journal of Hospital Medicine|March 27, 2015
A multifaceted hospitalist quality improvement intervention: Decreased frequency of common labsAdam H Corson, Vincent S Fan, Travis White, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 6, 2022
Comparison of Alternative Methods to Assess the Cost-Effectiveness of Tumor-Agnostic Therapies: A Triangulation Approach Using Larotrectinib as a Case StudyAndrew Briggs, Beth Wehler, Jennifer G Gaultney, et al.
Pageof 33